December 5, 2020 Comments Off on Investor Alert: Ampliphi Biosciences Corporation (nka Armata Pharmaceuticals Inc.) Blog, Current Investigations

Investor Alert: Ampliphi Biosciences Corporation (nka Armata Pharmaceuticals Inc.)

Investor Alert: Ampliphi Biosciences Corporation (nka Armata Pharmaceuticals Inc.), featured by top securities fraud attorneys, The White Law Group

Recovery of Investment Losses involving Ampliphi Biosciences Corp.

The White Law Group is investigating potential securities claims involving broker-dealers who may have unsuitably recommended Ampliphi Biosciences Corp. to investors.

According to a press release on May 9, 2019, C3J Therapeutics, Inc. and AmpliPhi Biosciences Corporation merged into a new combined company, known as Armata Pharmaceuticals, Inc. The new company will focus on the development and advancement of phage-based therapeutic candidates to treat antibiotic-resistant infections. Armata is currently trading on the NYSE American stock exchange under the symbol “ARMP.”

AmpliPhi Biosciences Corporation reportedly filed a form D to raise capital from investors in 2015. The total offering amount was purportedly $13,000,000.

According to Market Watch as of December 5, the share price of Armata Pharmaceuticals is down more than -30% in the past 12 months. 

The problem with pharmaceutical and biotech investments is that they typically involve a high degree of risk. The research and development process for pharma companies often involves costly and lengthy testing trials that yield specific data. If the expected data or end points are not met, that could be bad news for investors.

Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.

If a broker or brokerage firm makes an unsuitable investment recommendation or fails to adequately disclose the risks associated with an investment they may be found liable for investment losses in a FINRA arbitration claim. Fortunately, FINRA provides an arbitration forum for investors to resolve such disputes.

Recovery of Investment Losses

If you are concerned about your investment in Ampliphi Biosciences Corp., you may be able to file a complaint against your brokerage firm. Please contact the securities attorneys at The White Law Group at 1-888-637-5510 for a free consultation. 

The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois. The firm represents investors throughout the country in claims against their brokerage firm.

For more information on the firm and its representation of investors, visit  www.WhiteSecuritiesLaw.com.

Comments are closed.